Ferrous Glycine Sulphate

Ferrous Glycine Sulphate is a complex compound of glycine and ferrous sulfate, which is widely used as a supplement for iron fortification to treat iron deficiency anemia. The molecular formula for Ferrous Glycine Sulphate is C4H10FeN2O8S.  Iron is an essential mineral in hemoglobin, a protein responsible for carrying oxygen to different body parts. Iron deficiency causes less production of hemoglobin, iron deficiency anemia, and hypochromic anemia. Thus, the consumption of Ferrous Glycine Sulphate treats anemic conditions by supplementing iron to produce hemoglobin and red blood cells.

Get Your Ferrous Glycine Sulphate Complexes From WBCIL – India’s Most Trusted Supplier

Request Quote
  • Molecular Formula – C4H10FeN2O8S
  • Synonyms – Ferrous Glycine Sulphate, Iron (II) Glycine Sulfate
  • Molecular Weight – 04 g/mol

CAS No –

Shelf Life –

HSN Code –

Packing Size –

  • Storage Condition
    • It must be kept well-closed, dry, and at room temperature.
    • It must be kept protected against light,
  • Features – Free flowing, yellowish green to brownish yellow powder, with occasional friable lumps, hygroscopic in nature.
  • Solubility – Soluble in Water but insoluble in organic solvents such as Acetone, Ethanol, and Propanol.
  • Identification – Positive for Iron and Glycine.
  • Ferrous Content-
  • Glycine Content-
  • Other causes of anemia, such as Vitamin B and folate deficiency, must be ruled out before consuming Iron Glycine Sulphate as a supplement.
  • Iron Glycine Sulphate may not be harmful to the unborn fetus. However, it must be discussed with the physician beforehand about its consumption.
  • It is suggested that breastfeeding mothers avoid nursing while taking Ferrous Glycine Sulphate.


Pharmaceutical Uses

  • Ferrous Ascorbate is used for iron fortification.
  • It prevents and treats different anemic conditions, such as iron deficiency anemia and hypochromic anemia.
  • It is also consumed as a nutrient supplement for the production of hemoglobin and red blood cells in the body.


Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty

Abstract Background: Despite preoperative anaemia treatment, a risk of postoperative anaemia remains. This randomized, controlled study evaluated the efficacy of i.v. ferric carboxymaltose (FCM) as postoperative anaemia treatment after total knee arthroplasty (TKA). Methods: TKA patients with postoperative anaemia [haemoglobin...

Read more
Download Brochure
Contact Us